This website uses cookies
Read our Privacy policy and Terms of use for more information.
Jun 16, 2026
•
1 min read
MiniMed confirms via social media that the Flex (insulin delivery system) with the Simplera Sync sensor is officially shipping to its customers.
Jun 10, 2026
Senseonics has partnered with Welldoc to build a new Eversense 365 smartphoapp with Apple and Google Health integration and AI-powered features.
Jun 9, 2026
2 min read
Results from two Insulet studies presented at ADA point toward an automated future that demands less from the people using it.
Jun 8, 2026
Backed by two major clinical trials, Tandem's t:slim X2 and Tandem Mobi are now approved in Europe for use during pregnancy and in type 2 diabetes.
May 26, 2026
The timeline reflects recent FDA feedback and manufacturing progress, with pharmacy access, CGM compatibility, and no recharging required at launch.
Dexcom is urging patients and pharmacies to check lot numbers after two batches of scrapped CGM sensors were reportedly stolen and sold through a third party.
May 18, 2026
The CGM offers real-time glucose monitoring for adults with type 2 diabetes not on intensive insulin therapy.
May 13, 2026
The updated system combines the hybrid-patch pump with the new DBLG2 algorithm and the Dexcom G7 CGM with commercial launch expected for this summer.
May 12, 2026
6 min read
A side-by-side breakdown of the two most popular continuous glucose monitors used for diabetes management to help you choose which is right for you.
May 11, 2026
Tandem Diabetes' first tubeless insulin pump could reach the market by the end of 2026, creating an entirely new category of insulin pump.
May 4, 2026
The integration brings Dexcom's newest and longest-lasting CGM to the t:slim X2 automated insulin delivery system.
Insulet has enrolled its first participant in its EVOLVE trial testing an automated system designed to eliminate mealtime bolus announcements for people with type 2 diabetes.
Apr 30, 2026
The FDA has classified a Class I recall for certain Omnipod 5 lots after a tubing defect was linked to 476 serious injuries.
Apr 28, 2026
Sanofi's disease-modifying therapy can now be used in children as young as 1 year old, opening a new window to delay type 1 diabetes progression in the youngest patients.
Apr 27, 2026
Tandem's Control IQ+ becomes the only commercially available automated insulin delivery system approved for pregnancy use in the U.S.
Apr 24, 2026
The world's first one-year continuous glucose monitor is now available in Sweden, with Germany, Spain, and Italy to follow in the coming weeks.
The two have partnered to develop SC451, an investigational cell therapy aiming to restore the body’s ability to regulate glucose and eliminate the need for both insulin and immunosuppressive therapy.
Apr 23, 2026
The FDA has classified the Tandem Mobi insulin pump recall as Class I after a malfunction was found to disrupt insulin delivery and CGM communication.
Apr 16, 2026
Canadian MiniMed 780G users will have a new CGM option with the Simplera Sync, a smaller, calibration-free sensor designed for easier diabetes management.
Apr 14, 2026
3 min read
Niia Essential demonstrated proof of concept, strong performance and accuracy, and zero insulin delivery failures in its first clinical study.
Apr 9, 2026
Modular Medical's two-part tubeless patch design targets "almost-pumpers," with a planned U.S. commercial launch in Q2 2026.
Apr 8, 2026
Gravity-related pressure changes are causing incorrect insulin delivery, posing serious risks of dangerous highs and low glucose levels.
Apr 6, 2026
4 min read
The MiniMed Fit wear study is testing adhesive performance across body locations as the device moves closer to commercialization.
Apr 3, 2026
These water-activated evaporative cooling cases help keep insulin and other medications within safe temperature ranges during travel and extreme heat.
Apr 2, 2026
The new insulin reduces injections from daily to once-a-week while maintaining effective glucose control demonstrated in phase 3 clinical trials.
